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Solanum guaraniticum is a medicinal plant traditionally used to treat gastric and liver diseases. However, 
there is no documented evidence corroborating its safety. The present study evaluated the potential 
toxicity of S. guaraniticum leaf extract after acute administration in rats. Single doses of the extract 
(1.250, 2.500, and 5.000 mg/kg) were administered by gavage, and the rats were then monitored for 
48 h and/or 14 days. Mortality, acute signs of toxicity, and general activity in the open field test were 
assessed as well as hematological and biochemical parameters, enzymatic activity (δ-aminolevulinate 
dehydratase and acetylcholinesterase), and oxidative stress parameters (lipid peroxidation level, non-
protein thiol content, tissue catalase activity, and serum ferrous reducing power). Phytochemical analysis 
was also performed by HPLC. The results showed that extract administration produced no deaths  
(LD50 > 5,000 mg/kg), and no significant adverse effects regarding food consumption, body weight gain, 
gross pathology, or other parameters. However, the open field tests showed a decrease in spontaneous 
activity (crossing and rearing) mainly at 48 h after treatment. The results suggest that S. guaraniticum 
extract is not acutely toxic, but causes alterations in central nervous system activity.
Uniterms: Solanum guaraniticum/leaf extract/toxicity. Solanum guaraniticum/phytochemistry. Medicinal 
plants. Solanaceae.
Solanum guaraniticum é uma planta medicinal tradicionalmente usada para tratar doenças gástricas e 
hepáticas. Porém, não há evidências documentadas sobre sua segurança. O presente estudo avaliou a 
toxicidade do extrato das folhas de S. guaraniticum após administração aguda em ratos. Doses únicas 
do extrato (1.250, 2.500 and 5.000 mg/kg) foram administradas por gavagem e os animais foram 
monitorados por 48 h ou 14 dias. Mortalidade, sinais de toxicidade aguda e atividade geral, através do 
teste de campo aberto, foram analisados, assim como parâmetros hematológicos e bioquímicos, atividades 
enzimáticas (δ-aminolevulinato desidratase e acetilcolinesterase) e parâmetros de estresse oxidativo 
(nível de peroxidação lipídica, conteúdo de tióis não protéicos, atividade da catalase em tecidos e poder 
redutor em soro). A análise fitoquímica também foi realizada por HPLC. Os resultados mostraram que a 
administração do extrato não provoca mortes (LD50>5.000 mg/kg) ou efeitos adversos significativos com 
relação ao consumo de comida, ganho de peso corporal, análise patológica, entre outros. Entretanto, o 
teste de campo aberto mostrou uma diminuição na atividade espontânea geral (cruzamentos e levantadas), 
principalmente em 48 h após o tratamento. Portanto, nossos resultados sugerem que o extrato de S. 
guaraniticum não é agudamente tóxico, mas causa alterações na atividade do sistema nervoso central.
Unitermos: Solanum guaraniticum/extrato de folhas/toxicidade. Solanum guaraniticum/fitoquímica. 
Plantas medicinais. Solanaceae.
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INTRODUCTION
The consumption of medicinal plants has increased 
in recent years and has received much attention. According 
to the World Health Organization, between 70% and 
90% of the world´s population (primarily in developing 
countries), rely on plant-derived medicines for their 
healthcare (WHO, 2011). However, such traditional plants 
used for the treatment of diseases need further scientific 
investigation of their toxic side effects (WHO, 2008). 
Moreover, systematic toxicity studies, and especially 
pharmacological activity studies of these plants must be 
conducted in order to make their use safe and appropriate 
(Andrade, et al., 2012).
The Solanum genus is widely distributed throughout 
the world with approximately 1,400 species; it has a 
special importance to local economies, agriculture, and to 
the pharmaceutical sciences (Bohs, 2005). Of particular 
importance is Solanum guaraniticum A. St.-Hil, a yearlong 
flowering and fruiting shrub with broad and simple leaves, 
white flowers, and globose fruits that are yellow when 
ripe (Rech et al., 2006). The species occurs in Paraguay, 
Argentina, and Brazil (Stehmann et al., 2012), and is 
popularly known as “false-jurubeba”. The tea from its 
leaves is used to treat anemias, fevers, spleen and liver 
diseases, and as a tonic and digestive stimulant (Costa, 
1940; Simões et al., 1999).
Recent in vitro studies have demonstrated that 
Solanum guaraniticum leaf extract displays radical 
scavenger activity, and protective effects against oxidative 
injury in cells and tissues (Bonfanti et al., 2013, 2014; 
Zadra et al., 2012). The Brazilian Pharmacopoeia 
describes only S. paniculatum L. as the true jurubeba 
(Corrêa, 1984), yet interchangeable use of these two 
species by folk medicine is common.
Certain members of Solanaceae, including tomatoes 
potatoes and eggplants are known to contain varied 
steroidal glycol-alkaloids that are toxic to both humans and 
animals (Baker, Keeler, Gaffield, 1991; Jadhav, Sharma, 
Salunkhe, 1981). Yet there is paucity of pharmacological 
and toxicological data on such S. guaraniticum properties. 
Previous studies of a similar species, S. fastigiatum in high 
doses, have evidenced liver toxicity (Sabir, Rocha, 2008), 
which was also related to bovine intoxication, affecting the 
central nervous systems of the animals (Rech et al., 2006; 
Riet-Correa et al., 1983; Paulovich et al., 2002).
Toxicity in medicinal plants occurs at several levels 
in biochemical systems, and metabolic enzymes might 
well help for identification of these impairments. The 
enzyme acetylcholinesterase (AChE, EC 3.1.1.7) plays 
a major role in the regulation of several physiological 
events, and the activity of the cholinergic system is vital to 
normal behavior and muscular function (Schetinger et al., 
2000; Payne et al., 1996). As such, the crucial role of this 
enzyme in neural transmission makes it a primary target 
for a large number of cholinesterase-inhibiting drugs and 
toxins (Pohanka, 2011), and a valuable diagnostic tool 
for verifying exposure to chemical agents (Shenouda, 
Green, Sultatos, 2009). The heme pathway enzyme delta-
aminolevulinate dehydratase (δ-ALA-D, EC 4.2.1.24) 
presents high sensitivity to pro-oxidant situations, and 
to impairment of metabolic processes, thus being used 
to evaluate toxicity as well (Nogueira et al., 2003; 
Souza et al., 2009). Previous studies by our group have 
already demonstrated the inhibitory in vitro effects of S. 
guaraniticum extract on erythrocyte and brain δ-ALA-D, 
suggesting possible extract caused hematological and 
central nervous systems impairments (Bonfanti et al., 
2013, 2014).
Despite the popular use of S. guaraniticum for the 
treatment of various disorders, little scientific data is 
available regarding its safety, and there are no documented 
toxicological studies which can be used to ascertain safe 
dosages for its herbal preparations. The present study 
aimed to carry out an extensive acute toxicological 
evaluation of S. guaraniticum leaf extract in rats, including 
biochemical, hematological, and oxidative parameters, 
and also its effects on the general activity of the animals 
in an open-field test.
MATERIAL AND METHODS
Plant material
Leaves of S. guaraniticum were collected in the city 
of Santa Maria (Rio Grande do Sul, State of Brazil). The 
material was authenticated by Prof. Aline S. Pigatto, and 
a voucher specimen was deposited at the herbarium of the 
Federal University of Santa Maria (registration number: 
12980). The leaves were dried in a greenhouse, smashed 
in a knife mill, and submitted to extraction with ethanol 
80% in a Soxhlet apparatus until exhaustion. The extract 
was prepared at the proportion of 5 g of dried leaves 
to 100 mL of solvent. After extraction, the solvent was 
completely evaporated in a rotavapor system (Eidi, Eidi, 
Esmaeili, 2006), and analyzed by high-performance liquid 
chromatography (HPLC). Reverse phase chromatographic 
analyses were carried out under gradient conditions 
using a C18 column (4.6 mm × 250 mm), packed with 
5 μm diameter particles. The mobile phases were: (A) 
acetonitrile:water (95:5, v/v), and (B) water:phosphoric 
acid (98:2, v/v), the composition gradient was: 5% of A 
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until 10 min, and changing to obtain 20%, 40%, 60%, 70% 
and 100% A, at 20, 30, 40, 50 and 60 min, respectively. 
The flow rate was 0.7 mL/min, injection volume was 
40 μL, and the wavelengths were 254 nm for gallic 
acid, 280 nm for catechin and epicatechin, 327 nm for 
chlorogenic, ellagic, and caffeic acids, and 365 nm for 
rutin, isoquercitrin, quercitrin, kaempferol and quercetin. 
The chromatographic peaks were confirmed by comparing 
their retention times with those of reference standards, and 
by DAD spectra (200 to 500 nm).
Animals
Male adult albino Wistar rats (200-250 g) were 
maintained at 22 ± 2 °C and on a 12-h light/dark cycle 
allowing adaptation to laboratory conditions for one 
week prior to the start of the experiment. The animals 
were divided according to dosages, in groups of three rats 
for each treatment; the treatments were duplicated with 
different animals. Tap water and a standard pellet diet were 
provided ad libitum throughout the experiment, except 
for the short fasting period where the drinking water was 
still free to access but no food supply was provided for 
12 h prior to treatment. The animals were used according 
to the guidelines of the Committee on Care and Use of 
Experimental Animal Resources of the Federal University 
of Santa Maria, Brazil (Protocol 053/2012), and all efforts 
were made to minimize the number of animals used and 
their suffering.
Study design
Acute oral toxicity of the S. guaraniticum leaf 
extract was evaluated based on the procedures outlined 
by the Organization for Economic Co-operation and 
Development with minor modifications (OECD, 2001, 
2008; Rosidah et al., 2009; Hor et al., 2011). Following 
the 12 h fast, the extracts (suspended in water) were 
administered by oral gavage at single doses of 1.250, 
2.500 and 5.000 mg/kg to the respective groups (n = 6). 
Six animals received distilled water and were regarded 
as the control group. All treatments were administered at 
5 mL/kg body weight. 
Food was provided again to the rats approximately 
one hour after treatment. Visual observations: for mortality, 
behavioral pattern changes such as aggressiveness, food or 
water refusal, diarrhea, salivation, discharge from the eyes 
and ears, noisy breathing, changes in locomotor activity, 
piloerection, tremors, convulsion, coma, injury, pain, or 
any signs of illness in each treated group were monitored 
continuously for the first 4 h after dosing, and periodically 
until 48 h. At the end of the observation time, all the 
surviving rats were sacrificed by decapitation.
In a second experiment, animals were treated 
with the same doses of extract as described before, and 
observed for 14 days for abnormal clinical signs and death. 
Rats were weighed on days 1, 7, and 14 after treatment 
(Rosidah et al., 2009), with food and water consumption 
measured daily. Rats were also submitted to an open field 
test to analyze changes in spontaneous locomotor activity 
at 3 h, 48 h, and 14 days after the single dose treatments. 
All the surviving rats were sacrificed by decapitation on 
day 15.
Open field test
To analyze changes in spontaneous locomotor 
activity caused by the S. guaraniticum treatment, the 
animals were placed individually in an open field arena 
(100 × 100 × 50 cm) with black plywood walls and a 
white floor divided into 20 equal squares, as previously 
described (Broadhurst, 1960). The number of line 
crossings and rearings were measured over 5 min as well 
as the defecation rate.
Collection of blood and organ samples
At the end of both experiments (48 h and 14 days 
after the extract administration), the fasted animals were 
anesthetized by intraperitoneal injection of ketamine-
xylazine (90-13 mg/kg) and blood samples were collected 
by cardiac puncture into tubes respectively with or without 
EDTA for the hematological or biochemical analyses. 
Samples of the brain, liver, and kidney tissues were rapidly 
dissected, weighed, and placed on ice. The tissues were 
immediately homogenized in 10 mM Tris-HCl, ph 7.4 
(1/10 w/v). The homogenates were centrifuged at 4,000 x 
g at 4 °C for 10 min to yield a low-speed supernatant (S1) 
that was used for the determination of δ-ALA-D, AChE, 
and catalase (CAT) activity, thiobarbituric acid reactive 
substances (TBARS) levels, and thiol content (NPSH). 
The protein content of the S1 also was measured (Peterson, 
1977).
Organ macroscopic examination and organ-to-
body weight ratio
The liver, stomach, kidneys, lung, heart, spleen, 
and small intestines of all animals were observed 
macroscopically in situ, based on the position, color, 
shape, size, and consistency of the organs. Thereafter, 
vital organs such as the right kidney, the liver and the 
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spleen were necropsied and examined macroscopically 
for any lesions or abnormalities and the appearance of 
the individual organs in the treated and control groups 
was compared. Body and organ weights were measured 
and recorded. The relative organ weight of each animal 
was then calculated as follows: (absolute organ weight × 
100%)/ body weight of rat on the day of sacrifice (Malathi, 
Gomaz, 2008).
Biochemical and hematological analysis
EDTA-blood samples were analyzed for white 
blood cell count (WBC), red blood cell count (RBC), 
hemoglobin (Hb) concentration, hematocrit (Ht), red blood 
cell distribution width (RDW), mean corpuscular volume 
(MCV), mean corpuscular hemoglobin (MCH), mean 
corpuscular hemoglobin concentration (MCHC), platelet 
and differential leukocyte counts. Hematological analyses 
were performed using a fully automated hematological 
analyzer (KX-21N, Sysmex, Japan).
Blood samples for biochemical analyses were 
allowed to clot and centrifuged at 3.400 rpm for 
10 min (CELM LS-3 Plus, Brazil). The serum was 
collected and analyzed for the following biochemistry 
parameters: alanine aminotransferase (ALT), aspartate 
aminotransferase (AST), alkaline phosphates (ALP), 
albumin, glucose, total cholesterol, triglycerides, urea, and 
creatinine. Measurements of biochemical parameters were 
performed using commercial kits and a semi-automated 
analyzer (BIO-2000, Bioplus, Brazil).
Enzymatic assays
The δ-ALA-D activity in the liver, kidney, and 
cerebral cortex was assayed by Sassa method (1982). 
After a pre-incubation period, the enzymatic reaction was 
initiated by adding the substrate δ-aminolevulinic acid and 
incubation was carried out at 37° C for 1 h for the liver and 
kidney, and 3 h for the cortical homogenate. The incubation 
was stopped by adding a 10% trichloroacetic acid solution 
with 10 mM HgCl2. Porphobilinogen (PBG), which is 
formed during the incubation period, was mixed with a 
modified Ehrlich’s reagent, and the color developed was 
measured spectrophotometrically at 555 nm against a blank. 
The results were expressed as nmol PBG/mg protein/h. 
The AChE enzymatic assay in the cerebral cortex 
was determined by a modification of the Ellman et 
al. spectrophotometric method (1961), as previously 
described (Rocha, Emanuelli, Pereira, 1993). The reaction 
was initiated by adding 0.8 mM of acetylthiocholine iodide 
(AcSCh) to the reaction mixture (2 mL final volume), 
containing 100 mM TFK, pH 7.5, and 1 mM DTNB. 
The method is based on the formation of a yellow anion, 
5,5´-dithio-bis-acid nitrobenzoic, measured by absorbance 
at 412 nm during 2 min of incubation at 25 °C. The enzyme 
activity was expressed in µmol AcSCh/h/mg protein.
Oxidative stress parameters
Lipid peroxidation levels in liver, kidney and 
cerebral cortex tissues were estimated colorimetrically 
by measuring TBARS levels at 532 nm, according to 
the method of Buege and Aust (1978), and presented 
in nmol of MDA/mg protein. NPSH content in tissues 
was determined according to Ellman (1959) based on 
the development of the color yellow with DTNB, which 
is measured at 412 nm and presented as mmol GSH/mg 
protein. CAT activity was assayed by the decomposition 
of hydrogen peroxide according to the method of Aebi 
(1984) and expressed as mmol H2O2 consumed/min/mg 
protein. In addition, the total serum antioxidant power 
was determined using the ferric reducing (FRAP) assay, 
a colorimetric method based on the reduction of a ferric 
tripyridyltriazine complex to its ferrous form (Benzie, 
Strain, 1996). The results are presented as mM Fe2+.
Statistical analysis
The analyses were performed using Statistica for 
Windows, version 6.0 (StatSoft Inc. Tulsa, OK, USA). 
All data were analyzed using one way ANOVA followed 
by Duncan´s multiple range test and presented as 
mean ± standard error of mean (SEM). A value of p < 0.05 
was considered statistically significant for all analyses.
RESULTS
Phytochemical screening of S. guaraniticum 
extract
H P L C  r e v e a l e d  t h e  p r e s e n c e  o f  g a l l i c 
(tR = 10.36 min), chlorogenic (tR = 19.98 min) and 
ellagic acids (tR = 28.15 min), catechin (tR = 16.53 min), 
epicatechin (tR = 32.08 min), rutin (tR = 38.26 min), 
quercitrin (tR = 42.31 min), isoquercitrin (tR = 45.09 min), 
quercetin (tR = 48.63 min) and kaempferol (tR = 53.27 min) 
(Figure 1 and Table I).
General clinical observations
No death was recorded in any of the groups during 
the studied periods (48 h or 14 days). All treated animals 
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showed piloerection immediately after dosing, which 
lasted approximately 15 min. Thereafter, all animals 
behaved normally and no significant changes in general 
appearance or behavioral pattern were noted till the end 
of the observation times. Further, the consumption of food 
and water was similar between treated and control groups 
throughout the experiment (data not shown).
Open field test
In the open field test,  the rats treated with 
5,000 mg/kg of S. guaraniticum extract exhibited reduced 
total locomotor activity compared to the control group at 
48 h after dosing. When this parameter was evaluated at 
3 h and 14 days after treatment, no differences between 
treated and control animals were found (Figure 2).
The group treated with 5,000 mg/kg of extract 
also showed reduced rearing frequencies in the vertical 
exploration test at 3 h after dosing. However, a dose-
dependent reduction in the number of rearings was 
observed in all treated rats at 48 h after S. guaraniticum 
administration. Interestingly, this effect was not observed 
at 14 days after treatment, when there was no difference 
between treated and control groups (Figure 2).
In relation to defecation frequency, which may 
indicate anxiety levels, none of the treated animals 
presented differences from the control group for number 
of fecal pellets (data not shown).
Effect of the extract on organ weight and body 
weight gain
Normal body weight gains were observed in all 
groups after 14 days of treatment (control = 46.4 g ± 3.2; 
group 1,250 mg/kg = 45.2 g ± 6.5; group 2,500 mg/kg = 
40.6 g ± 4.1; group 5,000 mg/kg = 41 g ± 10.4). No 
significant difference was observed in the relative 
organ weights of the treated rats when compared to the 
controls, at 48 h or 14 days after dosing (Table II). Organ 
examination did not reveal any abnormalities or gross 
lesions. 
Effect of the extract on hematological and 
biochemical parameters
The hematological and biochemical profiles of the 
treated and control groups are presented in Tables III and 
IV, respectively. S. guaraniticum did not significantly alter 
either hematological or serum biochemical parameters as 
compared to the control animals.
Enzymatic activities and oxidative stress 
parameters
Acute treatment with S. guaraniticum extract did 
not promote any effects on the liver, kidney, or cerebral 
cortex, δ-ALA-D activity, or on cerebral cortex AChE 
activity (Table V).
In the kidney, there was a decrease in TBARS levels 
only at day 14 after treatment. Notwithstanding, the extract 
did not alter NPSH levels or CAT activity in the organs of 
the treated animals. Moreover, no significant difference 
was observed in FRAP levels between the treated and 
control groups (Table VI).
TABLE I - Quantification of phenolic compounds found by HPLC 
analyses of Solanum guaraniticum leaf extract
Compounds
S. guaraniticum extract
mg/g
Gallic acid 7.41 ± 0.03
Catechin 10.53 ± 0.01 
Chlorogenic acid 26.85 ± 0.06 
Ellagic acid 20.07 ± 0.02 
Epicatechin 4.71 ± 0.02 
Rutin 39.85 ± 0.01 
Quercitrin 11.36 ± 0.05 
Isoquercitrin 19.54 ± 0.01 
Quercetin 5.17 ± 0.01 
Kaempferol 9.73 ± 0.05
Results are expressed as mean ± SEM (n = 3)
FIGURE 1 -  Representative high performance liquid 
chromatography profile of Solanum guaraniticum leaf extract. 
Gallic acid (peak 1), catechin (peak 2), chlorogenic acid (peak 
3), ellagic acid (peak 4), epicatechin (peak 5), rutin (peak 6), 
quercitrin (peak 7) isoquercitrin (peak 8), quercetin (peak 9), 
and kaempferol (peak 10).
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DISCUSSION
Though medicinal plants remain the first line of 
treatment for many ailments in developing countries 
where access to modern health facilities is limited, very 
little is generally known about their toxicity. Since there 
are just few published studies about its toxicological 
profile, this paradigm also applies to S. guaraniticum. 
Despite the fact that efficacy is one of the overriding 
criterions in the selection of medicinal plants for use in 
health care systems, safety should never be overlooked 
and formal toxicological evaluation of medicinal plants 
should be performed as part of the validation process 
(Chan, 2003). In this sense, the present acute oral toxicity 
TABLE II - Body weight and organ body index of rats after 48 h and 14 days of S. guaraniticum treatment
Control 1250 mg/kg 2500 mg/kg 5000 mg/kg
48 h
Body weight (g) 216.8 ± 6.6 216.3 ± 11.6 214.5 ± 8.6 205.2 ± 7.1
Liver (%) 4.1 ± 0.3 4.23 ± 0.2 4.06 ± 0.3 3.87 ± 0.2
Kidney (%) 0.42 ± 0.01 0.41 ± 0.01 0.43 ± 0.02 0.40 ± 0.01
Spleen (%) 0.26 ± 0.02 0.27 ± 0.01 0.28 ± 0.01 0.26 ± 0.01
14 days
Body weight (g) 277.2 ± 7.3 278.8 ± 9.9 281.8 ± 11.6 249.3 ± 3
Liver (%) 3.66 ± 0.1 3.49 ± 0.1 3.54 ± 0.1 3.67 ± 0.2
Kidney (%) 0.36 ± 0.01 0.34 ± 0.01 0.36 ± 0.01 0.38 ± 0.03
Spleen (%) 0.21 ± 0.01 0.20 ± 0.01 0.21 ± 0.01 0.21 ± 0.03
Data are expressed as mean ± SEM of six rats per group.
FIGURE 2 - Open field exploration. The effect of different single doses of S. guaraniticum extract in rats was evaluated after 3 h, 
48 h, and 14 days of treatment. (A) Number of crossings in 5 min. (B) Number of rearings in 5 min. Data is presented as mean ± 
SEM of six rats per group. Asterisk denotes p < 0.05 compared to control group by one-way ANOVA followed by Duncan’s test.
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study has revealed the safety profile of S. guaraniticum 
leaf extract. On the basis of the presented results and under 
the conditions of this study, the lethal dose (LD50) of S. 
guaraniticum extract after a single oral administration in 
male Wistar rats is expected to be more than 5.000 mg/kg. 
Therefore, the extract may be characterized as nontoxic 
according to the classification proposed by Loomis and 
Hayes (Loomis, Hayes, 1996).
The reduction in the number of rearings and 
crossings may suggest that S. guaraniticum caused 
alterations in the activity of the central nervous system 
(Morais, Barbosa-Filho, Almeida, 1998; Mora et al., 
2005; Yasar et al., 2012). Further, it is interesting to note 
that the behavioral effects were more pronounced 48 h 
after treatment, and the behavior of the rats was similar to 
the controls at day 14 after treatment. In line with this, it 
is possible that the effect of S. guaraniticum extract may 
be delayed and short-lasting, since the animals showed 
normal behavior at the end of the second experiment.
General activity is an index for evaluating behavioral 
changes induced in animals, by not only physiological 
and genetic manipulation, but also by toxicological 
TABLE III - Hematological profile of rats after 48 h and 14 days of S. guaraniticum treatment
Control 1250 mg/kg 2500 mg/kg 5000 mg/kg
48 h
WBC (x103/mm3) 8.63 ± 1.28 9.05 ± 0.35 7.90 ± 1.42 7.21 ± 0.76
RBC (x106/mm3) 7.21 ± 0.14 7.08 ± 0.08 7.13 ± 0.19 7.35 ± 0.16
Hb (g/dL) 13.18 ± 0.18 13.33 ± 0.11 13.36 ± 0.19 13.42 ± 0.25
HCT (%) 42.03 ± 0.67 40.93 ± 0.45 41.76 ± 1.08 42.02 ± 0.65
MCV (fL) 58.35 ± 0.62 57.82 ± 0.47 58.58 ± 0.74 57.15 ± 0.58
MCH (pg) 18.28 ± 0.29 18.83 ± 0.18 18.68 ± 0.52 18.27 ± 0.38
MCHC (g/dL) 31.37 ± 0.2 32.58 ± 0.14 32.04 ± 0.56 31.93 ± 0.41
Platelets (x103/mm3) 1232 ± 66.2 1133 ± 66.5 1140 ± 83 1173 ± 58.76
RDW (%) 13.02 ± 0.24 13.33 ± 0.34 13 ± 0.41 13.88 ± 0.64
Eosinophils (%) 0.66 ± 0.21 0.83 ± 0.3 0.8 ± 0.2 1.5 ± 0.71
Monocytes (%) 2.66 ± 0.33 2.33 ± 0.33 2.6 ± 0.4 2.83 ± 0.47
Lymphocytes (%) 81.67 ± 2.34 72.17 ± 6.97 79.2 ± 2.78 76.83 ± 2.6
Neutrophils (%) 16.33 ± 2.49 23 ± 7.12 14.5 ± 3.5 19.17 ± 2.28
14 days
WBC (x103/mm3) 10.05 ± 1.05 9.93 ± 0.73 8.53 ± 1.05 8.91 ± 0.82
RBC (x106/mm3) 7.2 ± 0.06 7.4 ± 0.27 7.53 ± 0.11 7.85 ± 0.14
Hb (g/dL) 13.58 ± 0.2 13.43 ± 0.33 13.82 ± 0.19 14.17 ± 0.26
HCT (%) 41.65 ± 0.56 41.42 ± 1.04 42.85 ± 0.38 44.38 ± 0.58*
MCV (fL) 57.82 ± 0.47 56.07 ± 0.76 56.92 ± 0.74 56.57 ± 0.72
MCH (pg) 18.83 ± 0.21 18.2 ± 0.34 18.37 ± 0.44 18.03 ± 0.25
MCHC (g/dL) 32.62 ± 0.22 32.45 ± 0.18 32.27 ± 0.42 31.92 ± 0.35
Platelets (x103/mm3) 1045 ± 28 1210 ± 64.2 955.7 ± 104.6 937.3 ± 177
RDW (%) 11.87 ± 0.3 13.03 ± 0.4 12.05 ± 0.44 12.05 ± 0.21
Eosinophils (%) 0.83 ± 0.4 1 ± 0.51 0.33 ± 0.21 0.5 ± 0.34
Monocytes (%) 1.5 ± 0.42 2 ± 0.51 2.16 ± 0.47 0.83 ± 0.3
Lymphocytes (%) 78.5 ± 2.11 79.67 ± 2.6 76 ± 1.34 82.17 ± 1.32
Neutrophils (%) 16.33 ± 1.28 17.50 ± 2.48 20.33 ± 0.98 15.33 ± 0.95
White blood cell counts (WBC), red blood cells counts (RBC), hemoglobin (Hb), hematocrit (HCT), mean corpuscular volume 
(MCV), mean cell hemoglobin (MCH), mean cell corpuscular hemoglobin concentration (MCHC) and red blood cell distribution 
width (RDW). Data are expressed as mean ± SEM. Asterisk denotes p<0.05 compared to control group by one-way ANOVA 
followed by Duncan’s test.
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interference (Karl, Pabst, Von Hörsten, 2003). Among 
the techniques used to assess general activity, the open 
field enables various behavioral parameters related to 
emotional, exploratory and motor behavior to be measured 
(Ribeiro de Assis et al., 2006). The decrease in locomotor 
and rearing frequencies caused by S. guaraniticum 
extract administration suggests depressant and/or motor 
disturbance. This effect is similar to symptoms of cattle 
intoxication caused by Solanum species (Rech et al., 
2006; Riet-Correa et al., 1983; Paulovich et al., 2002), 
TABLE IV - Serum biochemical parameters of rats after 48 h and 14 days of S. guaraniticum treatment
Control 1250 mg/kg 2500 mg/kg 5000 mg/kg
48 h
AST (U/L) 95.83 ± 4.7 122.7 ± 21.15 115.7 ± 14.4 87.83 ± 3.45
ALT (U/L) 45.67 ± 3.73 52.67 ± 4.63 51.17 ± 7.78 42.33 ± 3.2
ALP (U/L) 721.7 ± 34.5 878.70 ± 97.5 612.80 ± 68.2 677.3 ± 75.9
Urea (mg/dL) 44.33 ± 4.24 48.00 ± 3.27 43.83 ± 3.88 47.33 ± 4.31
Creatinine (mg/dL) 0.43 ± 0.08 0.53 ± 0.04 0.53 ± 0.04 0.49 ± 0.06
Albumin (g/dL) 2.92 ± 0.17 2.87 ± 0.13 2.87 ± 0.1 3.07 ± 0.29
Glucose (mg/dL) 156.6 ± 9.6 158.1 ± 15.62 150.6 ± 9.18 148.2 ± 13.53
Cholesterol (mg/dL) 56 ± 6.27 57.12 ± 6.66 55.6 ± 5.24 56.62 ± 4.38
Triglyceride (mg/dL) 202.8 ± 12.76 185.9 ± 27.25 181.2 ± 22.66 157.2 ± 12.4
14 days
AST (U/L) 94.67 ± 8.26 107.8 ± 7.87 103.4 ± 9.35 97.8 ± 9.2
ALT (U/L) 36.17 ± 3 42.17 ± 3.69 44.83 ± 2.97 43.4 ± 5.11
ALP (U/L) 565 ± 31.2 513.8 ± 49.9 439 ± 13.8 624.8 ± 39.6
Urea (mg/dL) 40 ± 2.03 35.83 ± 1.86 36.17 ± 2.12 36.2 ± 2.17
Creatinine (mg/dL) 0.88 ± 0.25 0.56 ± 0.04 0.66 ± 0.09 0.58 ± 0.17
Albumin (g/dL) 2.88 ± 0.09 2.63 ± 0.12 2.93 ± 0.12 3.04 ± 0.17
Glucose (mg/dL) 194.6 ± 8.04 185.05 ± 15.71 180.6 ± 15.13 179 ± 14.87
Cholesterol (mg/dL) 64.81 ± 4 65.47 ± 4.34 62.53 ± 6.94 69.72 ± 5.2
Triglyceride (mg/dL) 187.5 ± 26.81 203.4 ± 18.34 217.8 ± 10.13 189.1 ± 28.38
Aspartate transaminase (AST), alanine transaminase (ALT), alkaline phosphatase (ALP). Data are expressed as mean ± SEM.
TABLE V - Tissue enzyme activity of rats after 48 h and 14 days of S. guaraniticum treatment
Control 1250 mg/kg 2500 mg/kg 5000 mg/kg
48 h
Liver δ-ALA-D 8.61 ± 0.57 9.82 ± 0.48 9.67 ± 0.91 8.55 ± 0.41
Kidney δ-ALA-D 3.66 ± 0.12 3.9 ± 0.33 3.96 ± 0.32 3.74 ± 0.23
Cortex δ-ALA-D 1.1 ± 0.08 1.17 ± 0.13 1.32 ± 0.13 1.09 ± 0.05
Cortex AChE 0.68 ± 0.06 0.9 ± 0.03 0.81 ± 0.1 0.82 ± 0.05
14 days
Liver δ-ALA-D 11.01 ± 0.32 11.64 ± 0.32 11.04 ± 0.28 10.32 ± 0.42
Kidney δ-ALA-D 4.58 ± 0.34 5.28 ± 0.27 4.24 ± 0.31 4.25 ± 0.29
Cortex δ-ALA-D 1.85 ± 0.44 1.82 ± 0.33 1.65 ± 0.33 1.78 ± 0.33
Cortex AChE 0.62 ±0.14 1.05 ± 0.08 0.93 ± 0.12 0.88 ± 0.2
δ-aminolevulinate dehydratase activity (δ-ALA-D; nmol porphobilinogen (PBG)/mg protein/h). Acetylcholinesterase actitivty 
(AChE; µmol AcSCh/h/mg of protein). Data are expressed as mean ± SEM.
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which includes locomotive incoordination and loss 
of equilibrium. Although this study does not present 
microscopic evaluation of brain tissues, these results 
should be further investigated prior to indication of this 
plant as a phytotherapeutic agent. Further, it is quite 
possible that the extract´s compounds are related to this 
activity, since it is known that a wide range of phenolic 
compounds interact directly with neurotransmitter systems 
and exert depressant effects (Kennedy, Wightman, 2011).
The similarity between the treated and control groups 
for food and water consumption and weight gain during 
the study period, as well as the compared hematological 
and biochemical profiles indicate that S. guaraniticum 
treatment did not cause significant adverse effects. 
Moreover, the treatment did not modify significantly the 
antioxidant status in animal tissues or serum, as assessed 
by the TBARS, NPSH and FRAP levels, and CAT activity, 
this excepting the kidneys where TBARS levels were 
decreased. The results suggest that the extract could have 
renal protective action.
Similarly, previous results in our laboratory have 
demonstrated the in vitro inhibitory effect of the extract 
on erythrocyte and brain δ-ALA-D activity, suggesting a 
hematologic and neurotoxic effect (Bonfanti el al., 2013, 
2014). However, the effect was not observed after in vivo 
acute treatment. This might be explained by the complex 
pharmacokinetic and pharmacodynamic characteristics 
of plant extracts (Rabbani, Sajjadi, Mohammadi, 
2008; Akindele, Adeyemi, 2010). Plant extracts are 
composed of various components, with mostly unknown 
pharmacological and dose-response data (Ahmed, Azmat, 
Azeem, 2004). The numerous bioactivities found in in vitro 
studies are not always meaningful to human health because 
the bioavailability of the natural product is often limited 
and only low plasma concentrations are detected in vivo 
(Villegas, Sánchez-Fidalgo, Alarcón de la Lastra, 2008). 
TABLE VI - Oxidative status of rats after 48 h and 14 days of S. guaraniticum treatment
Control 1250 mg/kg 2500 mg/kg 5000 mg/kg
48 h
Liver TBARS 0.54 ± 0.11 0.65 ± 0.19 0.46 ± 0.07 0.63 ± 0.13
Kidney TBARS 0.83 ± 0.14 0.76 ± 0.11 0.67 ± 0.12 0.54 ± 0.07
Cortex TBARS 2.66 ± 0.36 2.6 ± 0.31 2.62 ± 0.13 2.49 ± 0.12
Liver NPSH 2.79 ± 1.18 1.66 ± 0.09 1.57 ± 0.27 2.19 ± 0.22
Kidney NPSH 2.51 ± 0.46 3.38 ± 0.33 3.23 ± 0.68 3.22 ± 0.4
Cortex NPSH 9.11 ± 2.91 8.09 ± 2.19 7.6 ± 1.11 8.9 ± 2.94
Liver CAT 10.55 ± 0.52 10.98 ± 0.74 8.78 ± 0.25 9.87 ± 0.29
Kidney CAT 5.97 ± 0.2 5.92 ± 0.2 5.70 ± 0.51 5.59 ± 0.41
Cortex CAT 0.93 ± 0.21 0.89 ± 0.25 0.61 ± 0.09 0.55 ± 0.08
Serum FRAP 0.46 ± 0.03 0.53 ± 0.07 0.55 ± 0.08 0.51 ± 0.09
14 days
Liver TBARS 0.45 ± 0.12 0.69 ± 0.2 0.47 ± 0.08 0.59 ± 0.23
Kidney TBARS 1.50 ± 0.29 0.83 ± 0.08* 0.69 ± 0.1** 0.89 ± 0.08*
Cortex TBARS 4.04 ± 0.89 3.03 ± 0.89 2.39 ± 0.5 2.75 ± 0.32
Liver NPSH 3.24 ± 0.94 2.38 ± 0.7 2.60 ± 0.4 2.96 ± 0.75
Kidney NPSH 3.41 ± 0.47 2.73 ± 0.35 2.69 ± 0.32 3.73 ± 0.41
Cortex NPSH 5. 18 ± 0.33 6.53 ± 0.72 7.35 ± 1.03 7.44 ± 0.94
Liver CAT 8.52 ±0.3 8.46 ± 0.23 8.20 ± 0.14 8.28 ± 0.41
Kidney CAT 4.87 ± 0.12 4.58 ± 0.2 4.72 ± 0.15 4.79 ± 0.18
Cortex CAT 1.57 ± 0.6 1.59 ± 0.49 1.17 ± 0.39 1.03 ± 0.3
Serum FRAP 0.47 ± 0.04 0.56 ± 0.04 0.56 ± 0.02 0.48 ± 0.02
Thiobarbituric acid reactive substances (TBARS; nmol MDA (malondialdehyde)/mg protein). Non-protein thiol groups (NPSH; 
mmol GSH/mg protein). Catalase (CAT; mmol H2O2 consumed/min/mg protein). Ferric reducing power (FRAP; mM Fe2+). Data 
are expressed as mean ± SEM. *p < 0.05, **p < 0.01 compared to control group by one-way ANOVA followed by Duncan’s test.
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In this context, in vivo studies are helpful in clarifying the 
effective biological properties of a plant’s constituents thru 
considering metabolism and pharmacokinetics.
Toxicity studies in appropriate animal models are 
commonly used to assess potential health risks to humans. 
This is a key stage in ensuring the safety of drugs and an 
acute toxicity study is just one of the many types of toxicity 
tests that are used for such purposes (Asare et al., 2011). 
The fact that no lethal toxic effects were observed in the 
S. guaraniticum acute toxicity study indicates that plant 
preparations are safe for short-term treatments; and this 
low toxicity may have been responsible for its widespread 
use in varied ethno-therapeutic interventions. However, 
this assertion of safety may not be applicable to herbal 
preparation taken for a long period. To add further safety 
information a chronic toxicity study is recommended.
CONCLUSION
In conclusion, this study provides valuable data on 
the acute oral toxicity profile of S. guaraniticum. Based on 
the toxicological parameters evaluated, it can be concluded 
that this medicinal plant is not acutely toxic yet appears 
to possess some action on the general behavior of rats, a 
biological property that deserves greater attention. The 
results presented may be helpful for therapeutic decisions 
with respect to the toxicology of S. guaraniticum extract, 
and should be useful for any future in vivo or clinical study 
of this medicinal plant.
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